Finland· FI-REL-REL253

Antireema

A preparations with salicylic acid derivatives product containing diethylamine salicylate + hydroxyethyl salicylate + benzyl nicotinate + ethyl nicotinate, registered in Finland by Terpia Bernerin Lääketehdas Oy. The same ATC class is registered in 8 of our 19 countries.

ATC M02AC

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedAntireemaATCM02ACREGISTER NO.FI-REL-REL253PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Diethylamine salicylate + hydroxyethyl salicylate + benzyl nicotinate + ethyl nicotinate is registered in 8 of 19 countries.

Countries holding a registration under ATC M02AC (preparations with salicylic acid derivatives), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 5 of them publish a price we can compare per daily dose

Diethylamine salicylate + hydroxyethyl salicylate + benzyl nicotinate + ethyl nicotinate · ATC M02AC

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Diethylamine salicylate + Hydroxyethyl Salicylate + Benzyl nicotinate + Ethyl nicotinate
Manufacturer
Terpia Bernerin Lääketehdas Oy
Country
Finland (FI)
ATC code
M02AC
ATC class
Preparations with salicylic acid derivatives
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/40522da9-34ee-47b6-b8ae-27ca1c95ab9a
GET /v1/drugs/40522da9-34ee-47b6-b8ae-27ca1c95ab9a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "emulsiovoide",
  "route": null,
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Salisyylihappojohdoksia sisältävät valmisteet",
  "ma_number": "2280",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL253",
  "authorised_at": "1965-09-29"
}

See everything about diethylamine salicylate + hydroxyethyl salicylate + benzyl nicotinate + ethyl nicotinate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.